Perempuan Usia Muda Penderita DM Tipe 2 dengan Multikomplikasi
Laporan Kasus
DOI:
https://doi.org/10.55175/cdk.v51i12.1090Kata Kunci:
Diabetes melitus, komplikasi, ulkus dekubitusAbstrak
Diabetes melitus tipe 2 merupakan penyakit metabolik kronis progresif yang ditandai oleh kenaikan gula darah akibat resistensi insulin. Diabetes tidak terkontrol akan menyebabkan berbagai komplikasi akut ataupun kronis. Kasus pada penderita DM usia muda yang mengalami komplikasi status hiperglikemia hiperosmolar, iskemia serebral, dan ulkus dekubitus.
Unduhan
Referensi
Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2021. PB. PERKENI; 2021 .p. 46.
Kementerian Kesehatan. Keputusan Menteri Kesehatan Republik Indonesia No. HK.01.07/MENKES/603/2020 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Diabetes Melitus Tipe 2 Dewasa. 2021
Utami NL, Azam M. Kejadian penyakit jantung koroner pada penderita diabetes mellitus. Higeia 2019;3(2):311-23. DOI: 10.15294/higeia.v3i2.23692.
Rediningsih DR, Lestari IP. Riwayat keluarga dan hipertensi dengan kejadian diabetes melitus tipe II. J Penelit Pengembangan Kes Mas Indon. 2022;3(1):8-13. DOI: 10.15294/jppkmi.v3i1.52087.
Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG, Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care 2020;43(5):964-74. DOI: 10.2337/dc19-1614. PMID: 32139380.
Hammoudi J, Dahmani H, Bouanani NH, Nouayti H, Mekhfi H, Legssyer A, et al. Risk factors and diabetes related complications frequency in the population of the northeastern Morocco. Open J Epidemiol. 2018;8(03):164-85. DOI: 10.4236/ojepi.2018.83014.
Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: A global systematic review. Pharmacoeconomics 2015;33(8):811–31.DOI: 10.1007/s40273-015-0268-9.
Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient Prefer Adherence 2016;10:1299-307. DOI: 10.2147/PPA.S106821. PMID: 27524885; PMCID: PMC4966497.
Ceriello A, Prattichizzo F. Variability of risk factors and diabetes complications. Cardiovasc Diabetol. 2021;20(1):101. DOI: 10.1186/s12933-021-01289-4.
Maric-Bilkan C. Sex differences in micro- and macro-vascular complications of diabetes mellitus. Clin Sci (Lond). 2017;131(9):833-46. DOI: 10.1042/CS20160998. PMID: 28424377.
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the study of diabetes (EASD). Diabetes Care 2022; 45(11):2753–86. DOI: 10.2337/dci22-0034.
Ho LJ, Sheu WH, Lo SH, Yeh YP, Hwu CM, Huang CN, et al. Unhealthy lifestyle associated with increased risk of macro-and micro-vascular comorbidities in patients with long-duration type 2 diabetes: Results from the Taiwan Diabetes Registry. Diabetol Metabolic Syndrome 2023;15(1):38. DOI: 10.1186/s13098-023-01018-9.
Poggiogalle E, Jamshed H, Peterson CM. Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism. 2018;84:11-27.DOI: 10.1016/j.metabol.2017.11.017. PMID: 29195759; PMCID: PMC5995632.
Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. 2012;16(Suppl 1):S27-36. DOI:10.4103/2230-8210.94253.
Sharma D, Farrar JD. Adrenergic regulation of immune cell function and inflammation. Seminars Immunopathol. 2020;42(6):709-17. DOI: 10.1007/s00281-020-00829-6.
Verberne AJM, Korim WS, Sabetghadem A, Llewellyn-Smith IJ. Adrenaline: Insights into its metabolic roles in hypoglycaemia and diabetes. BJP.2016;173(9):1425-37. DOI:10.1111/bph.13458.
Elendu C, David JA, Udoyen AO, Egbunu EO, Ogbuiyi-Chima IC, Unakalamba LO, et al. Comprehensive review of diabetic ketoacidosis: An update. Ann Med Surg (Lond). 2023;85(6):2802-7. DOI: 10.1097/MS9.0000000000000894.
Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, Ellis SE, O Sullivan PS. Hyperosmolarity and acidosis in diabetes mellitus: A three-year experience in Rhode Island. J Gen Intern Med. 1991;6(6):495-502. DOI: 10.1007/BF02598216. PMID: 1765864.
Mahmuda IN. Pencegahan dan tatalaksana dekubitus pada geriatri. Biomedika 2019;11(1):11-7. DOI: 10.23917/biomedika.v11i1.5966.
American Diabetes Association. 10. Cardiovascular disease and risk management: Standards of medical care in diabetes-2021. Diabetes Care 2021;44(Suppl 1):S125-S50. DOI: 10.2337/dc21-S010. Erratum in: Diabetes Care. 2021;44(9):2183-5. PMID: 33298421.
Xiang B, Zhao X, Zhou X. Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients. Cardiovasc Diabetol. 2021 Apr 7;20(1):78. DOI: 10.1186/s12933-021-01266-x. PMID: 33827579; PMCID: PMC8028072.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. DOI: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13. Erratum in: J Am Coll Cardiol. 2018;71(19):2275-2279. PMID: 29146535.
Sharma A, Rizky L, Stefanovic N, Tate M, Ritchie RH, Ward KW, et al. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction. Cardiovasc Diabetol. 2017;16(1):33. DOI: 10.1186/s12933-017-0513-y. PMID: 28253885; PMCID: PMC5335831.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2024 Lian Adhalia, , Iin Novita Nurhidayati Mahmuda
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
